ArticleTherapeutics and clinical risk management2024
Comparison of Efficacy and Safety Outcomes of Different Doses Schedules of Thalidomide for Treating Moderate-to-Severe β-Thalassemia Patients.
Wei-Jia Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.